Albumin fusion with human lactoferrin shows enhanced inhibition of cancer cell migration
Crossref DOI link: https://doi.org/10.1007/s10534-022-00447-9
Published Online: 2022-09-27
Published Print: 2023-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Nopia, Hana
Kurimoto, Daisuke
Sato, Atsushi http://orcid.org/0000-0003-1359-8905
Text and Data Mining valid from 2022-09-27
Version of Record valid from 2022-09-27
Article History
Received: 8 July 2022
Accepted: 14 September 2022
First Online: 27 September 2022
Declarations
:
: A. Sato was the founder of S&K Biopharma Inc. (Kawasaki, Kanagawa, Japan).